SCHEMBL3606322

SCHEMBL3606322

CCCNCCCC(C)(C)N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.42
ALDH1A1 P00352 1/20 0.42
PAOX Q6QHF9 1/20 0.39
CYP2C19 P33261 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
GLA P06280 1/20 0.36
CYP1A2 P05177 2/20 0.35
CA12 O43570 2/20 0.32
CA2 P00918 2/20 0.32
CA4 P22748 2/20 0.32
CA6 P23280 2/20 0.32
CA5A P35218 2/20 0.32
CA7 P43166 2/20 0.32
CA9 Q16790 2/20 0.32
CA14 Q9ULX7 2/20 0.32
CA5B Q9Y2D0 2/20 0.32
CA3 P07451 1/20 0.32
CASP2 P42575 2/20 0.31
HRH4 Q9H3N8 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4621138 0.85 ALDH1A1 (0.33) TSHRALDH1A1PAOX
SCHEMBL10454333 0.81 TSHR (0.48) TSHRALDH1A1CYP2C19MEN1KMT2A
SCHEMBL342046 0.81 CA12 (0.55) TSHRALDH1A1PAOXCYP2C19MEN1
SCHEMBL12011756 0.80 TSHR (0.46) TSHRALDH1A1PAOXCYP2C19MEN1
SCHEMBL11508572 0.80 TSHR (0.46) TSHRALDH1A1PAOXCYP2C19MEN1
SCHEMBL9239450 0.79 TSHR (0.46) TSHRALDH1A1PAOXCYP2C19MEN1
SCHEMBL9240291 0.79 TSHR (0.46) TSHRALDH1A1PAOXCYP2C19MEN1
SCHEMBL9106221 0.79 TSHR (0.46) TSHRALDH1A1PAOXCYP2C19MEN1
SCHEMBL9239138 0.79 TSHR (0.46) TSHRALDH1A1PAOXCYP2C19MEN1
Tert-Butylamine SCHEMBL21925351 0.79 TSHR (0.40) TSHRALDH1A1PAOXCYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1740559-B1 1,3,5-SUBSTITUTED PHENYL DERIVATIVE COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK SHARP & DOHME (US) 2014-10-15 EP disclosed
US-7847100-B2 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease Merck, Sharp & Dohme, Inc. (US) 2010-12-07 US disclosed
US-20070244119-A1 1,3,5-Substituted Phenyl Derivative Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease MERCK SHARP & DOHME LLC 2007-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070244119-A1 1,3,5-Substituted Phenyl Derivative Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease BACE1, BACE2, PSEN1 TSHR 4859/4885ALDH1A1 989/4885PAOX 2307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.